1. Merck leaps into COVID vaccine race — Evofem Biosciences gets FDA approval for new non-hormonal contraceptive — Sanofi sells $13 billion stake in Regeneron — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Not Allowed to Market in US!

Discussion in 'Braeburn Pharmaceuticals' started by anonymous, Dec 23, 2018 at 3:25 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Patients will not opt for weekly treatments. I won’t be making the move over it’s not worth it anymore.
     

  2. anonymous

    anonymous Guest

    Loving the Sublocade advertising on this board
     
  3. anonymous

    anonymous Guest

    Feeling the BURN?! As in BraeBURN! Biggest idiots in the industry! The only people dumber than these guys are the shmucks providing them with the capital to fund their failures. How do you not see this coming?!
     
  4. anonymous

    anonymous Guest

    So someone posted a good question. Why do you think that the weekly will be allowed to launch at all? Exclusivity is exclusivity. It does not say anywhere that I have read that the weekly option can be marketed while the monthly dose option has to wait.

    I think we are getting ahead of ourselves here. I am not planning on being able to accept the offer because I expect it to be retracted.
     
  5. anonymous

    anonymous Guest

    Talk about brain dead, they rescinded the offers the day they made the announcement. Check ur emails dumbass!
     
  6. anonymous

    anonymous Guest

    Does anyone know if they will offer partial reimbursement for cell phone or home internet?
     
  7. anonymous

    anonymous Guest

    You’re joking right?
     
  8. anonymous

    anonymous Guest

    I really want to know. Do you think we will have decent lunch budgets to secure valuable selling time? I really think we can impact patient outcomes but in a smaller organization oftentimes the resources can be limited.

    Thanks.
     
  9. anonymous

    anonymous Guest

    It’s the only way you’ll get any time in this disease space if they even see you. Patients do not want weekly injections so good luck
     
  10. anonymous

    anonymous Guest

    Patients and physicians will embrace the weekly option in those treatment situations where it makes sense to ensure compliance. It's wonderful to offer a tailored approach.
     
  11. anonymous

    anonymous Guest

    OK, then with all that being said, when is our start date? When do we start our training on this product?
    This wait and see is killing me. I need to work and have already turned down other opportunities to be here.
     
  12. anonymous

    anonymous Guest

    Good luck. Patients don’t even want to come in for a monthly let alone a weekly.
     
  13. anonymous

    anonymous Guest

    Am I missing something? Why the hell are people asking what the car allowance is, lunch budget etc? The offers were rescinded you don’t have a job at Braeburn, wake up idiots!
     
  14. anonymous

    anonymous Guest


    Yes, you are missing it which makes you the idiot for even responding.
    We are just having fun with all these posts since idiots like you use this site for information.
    Braeburn deserves all this ridicule for not doing their due diligence and now those who thought this was a done deal will have to go back to their mediocre rep jobs.
     
  15. anonymous

    anonymous Guest

    I debated for a whole 2 seconds if this deserved a response because I didn't want to waste anymore of my time. You must have a happy and fulfilling work life balance if this is how you spend your time? Sarcasm on CafePharma....sorry I wasted time reading your idiotic post. You must feel good about yourself and your career to be trolling on this thread!
     
  16. anonymous

    anonymous Guest

    where is MT hiding? she was on LinkedIn 10x day with all her posts and comments. guess all her talk about transparency and great corporate culture were a lie. Thank you Michelle for never getting back to me and forcing me to look elsewhere, you got what you deserve and should never be in a leadership position again:D
     
  17. anonymous

    anonymous Guest


    Why do you think she had some of the highest rep turnover with Cephalon and Teva? No loyalty from her team. She was someone who was always looking for something to catch you on just to put you on a PIP. Back stabbing non-leader.
     
  18. anonymous

    anonymous Guest

    If it is shipped as 4 weekly injections in one shipment these syringes are for a specific patient What a logistical nightmare to manage multiple doses that can only be given to a specific patient. On top of that this is a very unreliable patient base offices will going crazy trying to manage all the missed weekly appointments multiple doses and logistics of each patients specific drug. Plus SP takes about 10 steps to order plus PA process plus no insurance coverage. Sounds like a winner to me!!!!!!
     
  19. anonymous

    anonymous Guest

    OMG. Can’t imagine the logistical
    Nightmare of managing 10 patients on weekly different doses drug for a specific patient patients not showing up or abandoning drug patients all running out of drug on a different date and most of these offices have doctor receptionist and maybe one additional. Plus they get to have a narcotic permanently stored in their office. GOOD LUCK. With that.
     
  20. anonymous

    anonymous Guest

    Not once but TWICE with the same product. Everyone who got offers should proceed with caution.